Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesSafe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Technical issues: flow cytometry and rare event analysis.Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemiaMinimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing.Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.Significance of CD99 expression in T-lineage acute lymphoblastic leukemia.Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression.Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG).High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.
P2860
Q24604581-5ACD8B21-1CB3-4438-9921-3B99E2ADFBAEQ30300395-9BE75CF1-43A6-4BE2-B29A-B9969EE7CE61Q34670653-B4BCDC2C-DB23-4A7E-AC06-F0A993861D4FQ36169572-36235D89-39DC-4CC3-A85C-0A7BC422E6FDQ36371093-642EFF00-130E-4F3A-9A42-49DEDCD77D3FQ37307811-007AE8F6-7298-4ED5-9278-8B55D22E9DA8Q38438814-430CC6D3-30C6-4594-AA44-4836CEEEEF88Q40839368-690B18A1-A261-4C3C-8DC9-4540EAD274F1Q41522009-92BD9608-9A5A-4F5E-9D7A-64D7B3864669Q44670719-48E5E1D2-9D99-4EFD-B343-1D2BFE1A870EQ44721604-CD9238AA-41A0-489C-8799-AF68D88AE8F2Q45309842-E3FF1A8C-DC1D-4D1A-81DA-B2288231A597Q45957538-17FC75B5-1E3F-4D51-A3A0-0B8941D2A256Q48096830-8597F1CD-2EF4-4CEA-9744-9477D54DD8BCQ49497206-4E65888B-6BB7-402D-AAC0-4B9621F16308Q51738618-9CA97036-948E-4AEA-ACB3-7853EDA866B8Q54309630-5936182A-3CF8-4BB3-A814-D8983C2E65E9
P2860
Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immaturity associated antigens ...... al residual disease detection.
@ast
Immaturity associated antigens ...... al residual disease detection.
@en
type
label
Immaturity associated antigens ...... al residual disease detection.
@ast
Immaturity associated antigens ...... al residual disease detection.
@en
prefLabel
Immaturity associated antigens ...... al residual disease detection.
@ast
Immaturity associated antigens ...... al residual disease detection.
@en
P2093
P2860
P356
P1476
Immaturity associated antigens ...... al residual disease detection.
@en
P2093
Brent L Wood
Jonathan R Fromm
Mikhail Roshal
Stuart Winter
P2860
P304
P356
10.1002/CYTO.B.20511
P577
2010-05-01T00:00:00Z